Cell & Gene Therapy Intelligence Platform
Real-time insights for the global cell and gene therapy industry
$47B
Projected Market Size by 2035
2.3M+
Patients Treated Globally
3,000+
Active Pipeline Programs
500+
Global manufacturing facilities
Analyze the Cell & Gene Therapy in Real-Time
Track the Cell & Gene Therapy Market in Real Time Empowering biotech, pharma, and investors with live insights and data.
Market Forecast
Therapy Pipelines
Pricing Intelligence
Market Growth Forecast
The cell and gene therapy market is projected to experience robust growth over the next decade, driven by increasing clinical success rates, expanding therapeutic applications, and rising investment from biotech and pharmaceutical companies. Advancements in manufacturing technologies and regulatory support are accelerating commercialization, positioning the market to reach approximately $45–50 billion globally by 2035.
Therapy Pipeline Intelligence
Therapy pipeline intelligence provides a comprehensive view of over 3,000 cell and gene therapy programs across discovery, preclinical, and clinical stages. It enables stakeholders to track innovation trends, assess competitive landscapes, identify high-potential assets, and make informed strategic decisions with real-time, data-driven insights.
Manufacturing capacity Tracker
Manufacturing capacity tracking offers real-time visibility into global cell and gene therapy production infrastructure, covering over 500 facilities worldwide. It helps stakeholders monitor capacity expansion, assess supply chain readiness, identify regional strengths, and optimize manufacturing strategies to support growing clinical and commercial demand.
Pricing & Economic impact
Pricing and economic impact analysis evaluates the cost structures and value frameworks of cell and gene therapies across global markets. It helps stakeholders understand pricing trends, reimbursement dynamics, budget impact, and long-term cost-effectiveness, enabling informed decisions for commercialization, access strategies, and sustainable healthcare adoption.
Discover the Leading Cell & Gene Therapy Intelligence Platform
Unlock exclusive cell and gene therapy insights, personalized demos, and tailored data solutions today.
Recent News
Recent Industry News Updates
Sysmex Launches UC-1100 Urinalysis Platform
Sysmex introduces the UC-1100 urinalysis platform, enhancing diagnostic accuracy, speed, and efficiency in routine laboratory testing.
JustFoodForDogs JustFresh Dog Diets Launch with Fresh Targeted Nutrition
JustFoodForDogs launches JustFresh, a new line of fresh, shelf-stable dog food with targeted nutrition to support pet health, improve diet quality, and meet growing demand in the pet therapeutic diet market.
Terumo RAPClot Blood Collection Tubes Launch in Japan for Faster Diagnostics
Terumo Corporation launches RAPClot blood collection tubes in Japan using Q-Sera Pty Ltd technology to improve lab efficiency, reduce testing time, and enhance patient outcomes.
Picarro PI2124 Analyzer for VHP Monitoring in Pharmaceutical Manufacturing
Picarro Inc. introduces the PI2124 Analyzer, a new solution for real-time monitoring of vaporised hydrogen peroxide (VHP) in pharmaceutical and regulated industries, improving safety, compliance, and efficiency.
1 million+
products
500000+
companies profiled
1200
active clients globally
50+
countries served
Report
Get Facts and Insights on Topics that Matter
Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market Size to Hit USD 5,275.10 Million by 2035
The global automation, digitization and robotics in cell and gene therapy manufacturing market size was evaluated at USD 950.00 million in 2025 and is predicted to hit around USD 5,275.10 million by 2035, growing at a CAGR of 18.70%.
Read More ↗Cell and Gene Therapy Market Size to Surpass USD 47.18 Bn By 2035
The global cell and gene therapy market size was calculated at USD 8.94 billion in 2025 and is projected to surpass around USD 47.18 billion by 2035 with a solid CAGR of 18.1%.
Read More ↗Pyrogen Testing Market Size to Hit USD 4.50 Billion by 2035
The global pyrogen testing market size was evaluated at USD 1.72 billion in 2025 and is predicted to hit around USD 4.50 billion by 2035, growing at a CAGR of 10.10%.
Read More ↗Explore AI implications and find more opportunities through our articles
Our Clients
